All News

Latest Immunotherapy Drugs Market Report- by Type, Therapy Area and Global Forecast | Sanofi, GlaxoSmithKline Plc

ReportsnReports added Immunotherapy Drugs Market Research Report created by Report Consultant, which offers detailed insights, revenue details, and other information regarding the global market, and the various trends, drivers, restraints, opportunities, and market till 2028. Immunotherapy Drugs Market Report offers detailed information regarding the leading key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions and mergers, and market footprint. Immunotherapy Drugs Market also provides a comparative analysis of the market dynamics pre and post Covid19 outbreak.

Request for FREE PDF Sample Report @

 “The immunotherapy drugs market is projected to grow at a CAGR of 11.0% during the forecast period (2020–2025).”

Top Company Profile Analysis in this Report- F. Hoffmann-La Roche Ltd. (UK), Pfizer Inc. (US), Merck & Co (US), Novartis International AG (UK), Johnson & Johnson (US), Sanofi (France), GlaxoSmithKline Plc (UK), Amgen Inc. (US), AbbVie Inc. (US), Boehringer Ingelheim (Germany), AstraZeneca (UK), and Immatics Biotechnologies (Germany), BioNTech SE, Genmab, Gilead Sciences, NBE Therapeutics, Teva Pharmaceuticals, Bayer, and Bristol-Myers Squibb.

The global immunotherapy drugs market is projected to reach USD 274.6 billion by 2025 from USD 163.0 billion in 2020, at a CAGR of 11.0 % during the forecast period. Market growth is primarily driven by the rising demand for immunotherapies over conventional treatments and a growing prevalence of target indications. However, timeline issues, side-effects, and manufacturing complexities are expected to restrict market growth to a certain extent.

The adoption of immunotherapy in cancer has been rising in recent years due to the introduction of safe and efficient treatments. Monoclonal antibodies are immunoglobulins derived by cultivating immune cells in the lab to target specific antigens present on the surface of cancer cells. These antibodies, when used as a therapy, attach themselves to cancer/abnormal cells and mark them for destruction by the body’s natural immune system. Monoclonal antibodies hold the largest share of the immunotherapy drugs market owing to their high specificity and few side-effects.

The report analyzes the immunotherapy drugs market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, application, end user, and region. The report also includes competitive analyses of the key players in this market, along with their company profiles, product and service offerings, recent developments, and key market strategies.

Single User License: US $ 4950
Get FLAT 25% Discount on this Report @

Reasons to Buy the Report-

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the immunotherapy drugs market. The report analyzes the market based on type, therapeutic area, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the immunotherapy drugs market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of immunotherapy drugs solutions across regions
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the immunotherapy drugs market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the immunotherapy drugs market

Table Of Contents in this Report-

1 Introduction
1.1 Objectives Of The Study
1.2 Market Scope
1.2.1 Markets Covered
1.2.2 Years Considered For The Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data Key Data From Secondary Sources
2.1.2 Primary Data Key Data From Primary Sources Breakdown Of Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown And Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions For The Study

3 Executive Summary

4 Premium Insights
4.1 Immunotherapy Drugs Market Overview
4.2 North America: Immunotherapy Drugs Market, By Type (2019)
4.3 Geographic Snapshot Of The Immunotherapy Drugs Market
4.4 Pipeline Of Phase 2/3 Immunotherapy Drugs

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers Increasing Adoption Of Immunotherapy Drugs Over Conventional Treatment Regimens Rising Prevalence Of Cancer And Autoimmune & Infectious Diseases Increasing Demand For Monoclonal Antibodies And Biosimilars
5.2.2 Restraints Timeline Issues, Side-Effects, And Manufacturing Complexities High Attrition Rate In The Product Development Cycle
5.2.3 Opportunities Increased Demand For Personalized Medicines High Scope For Growth In Emerging Economies Development Of Affordable Nanoparticles For Deploying Immunotherapies
5.2.4 Challenges High Cost Of Immunotherapy Treatment, Regional Disparities, And Lack Of Insurance Coverage Side-Effects And Low Efficacy Of Immunotherapy Drugs Lack Of Awareness Delays In Diagnosis And Treatment
5.2.5 Impact Of The Covid-19 Pandemic On The Immunotherapy Drugs Market

6 Immunotherapy Drugs Market, By Type
6.1 Introduction
6.2 Monoclonal Antibodies
6.2.1 Monoclonal Antibodies Accounted For The Largest Share Of The Market In 2019
6.3 Checkpoint Inhibitors
6.3.1 Checkpoint Inhibitors Market To Grow Owing To Their Wide Applicability In Numerous Cancer Treatments
6.4 Interferons & Interleukins
6.4.1 Interferons & Interleukins Use The Patient’s Immune System, Which Provides Significant Benefits
6.5 Other Immunotherapies

7 Immunotherapy Drugs Market, By Therapeutic Area
7.1 Introduction
7.2 Cancer
7.2.1 Malignant Cancers Malignant Cancers Held The Largest Share Of The Immunotherapy Drugs Market In 2019
7.2.2 Benign Cancers Availability Of A Range Of Drugs For Benign Cancer Treatment Supports Market Growth
7.3 Autoimmune & Inflammatory Diseases
7.3.1 Strong Demand For Immunotherapies Bolsters Market Growth In This Segment
7.4 Infectious Diseases
7.4.1 Increasing Prevalence And Rise In R&D Support Market Growth
7.5 Other Therapeutic Areas

8 Immunotherapy Drugs Market, By End User
8.1 Introduction
8.2 Hospitals
8.2.1 Hospitals Accounted For The Largest Share Of The Immunotherapy Drugs Market
8.3 Clinics
8.3.1 Clinics Provide Focused, Primary-Level Care For Patients And Cannot Provide Advanced Treatments
8.4 Other End Users

9 Immunotherapy Drugs Market, By Region

and more…